Olipop is a prebiotic soda brand launched in 2018 that sells fiber-rich soft drinks as alternatives to traditional sodas. The company plans to use the new funding to add to its product lineup, expand marketing, and broaden distribution. Based on dollar sales and unit growth, Olipop is one of the top nonalcoholic beverage brands in the U.S. CNBC reported that Olipop's annual sales surpassed $400 million last year, doubling the previous year. The company reached profitability in early 2024. Founders Ben Goodwin and David Lester initially funded Olipop with $100,000 from the sale of their prior drink Obi; in its first year in Northern California the brand sold in 40 grocery stores and reached $852,000 in gross revenue. Olipop makes a line of prebiotic, plant-fiber sodas formulated to support digestive health using prebiotics and botanical ingredients. The product line is positioned as a ‘functional soda’ and Olipop says it accounts for two-thirds of the niche’s revenue. The company has completed in‑vitro trials with Baylor and Purdue and has a human clinical underway, and plans to expand R&D and new flavors. Distribution has scaled from an initial 45 northern California stores to more than 10,000 grocers nationwide, including Kroger, Target, Whole Foods, Sprouts, Safeway and Wegmans. Olipop grew top-line revenue threefold in 2021, anticipates a $100M run-rate by the end of 2022, is not yet profitable but is headed toward profitability, and has expanded headcount to around 60 employees. The company plans to use new funding for hiring, marketing and product inventory to support rapid distribution expansion.

Total raised

$80M

Funding rounds

2

Latest round

Series C

Latest activity

Feb 2025